Co-occurrence of serious or undiagnosed medical conditions with bipolar disorder preventing clinical trial randomization: A case series

Journal of Clinical Psychiatry

Volumn 73, Issue 6, 2012, Pages 874-877

  Feldman, Natalie S ^a,c   Gwizdowski, Iola S ^a   Fischer, E Grace ^a   Yang, Huaiyu ^a,b   Suppes, Trisha ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CARDIOVASCULAR RISK; CASE STUDY; CAUCASIAN; CLINICAL ARTICLE; CO OCCURING MEDICAL CONDITION; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; MALE; OUTPATIENT DEPARTMENT; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING TEST; SELF REPORT;

EID: 84863547599     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07331     Document Type: Article

References (18)

1. Kilbourne AM, Cornelius JR, Han X, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6(5):368-373. doi:10.1/j.139-5618.204.0138.x PubMed (Pubitemid 39345287)
2. Peele PB, Xu Y, Kupfer DJ. Insurance expenditures on bipolar disorder: clinical and parity implications. Am J Psychiatry. 2003;160(7):1286-1290. doi:10.176/api.ajp.160.7.1286 PubMed (Pubitemid 41070945)
3. Ostacher M. (2011). Changing health related behaviors: can real-time interventions improve the course of bipolar disorder? International Conference on Bipolar Disorder (ICBD); June 9-11, 2011;Pittsburgh, PA.
4. Black DW, Winokur G, Bell S, et al. Complicated mania. Comorbidity and immediate outcome in the treatment of mania. Arch Gen Psychiatry. 1988;45(3):232-236. doi:10.101/archpsyc.198.0180270405 PubMed (Pubitemid 18081671)
5. Pirraglia PA, Biswas K, Kilbourne AM, et al. A prospective study of the impact of comorbid medical disease on bipolar disorder outcomes. J Affect Disord. 2009;115(3):355-359. doi:10.1016/j.jad.208.09.020 PubMed
6. Ruzickova M, Slaney C, Garnham J, et al. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can J Psychiatry. 2003;48(7):458-461. PubMed (Pubitemid 37295203)
7. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42. PubMed
8. Ösby U, Brandt L, Correia N, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58(9):844-850. doi:10.101/archpsyc.58.9.84 PubMed (Pubitemid 32979302)
9. Fenn HH, Bauer MS, Altshuler L, et al; VA Cooperative Study #430 Team. Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. J Affect Disord. 2005;86(1):47-60. doi:10.1016/j.jad.204.12.06 PubMed (Pubitemid 40487959)
10. Leverich GS, McElroy SL, Suppes T, et al. Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry. 2002;51(4):288-297. doi:10.1016/S06-323(01)01239-2 PubMed (Pubitemid 34214994)
11. Walker EA, Gelfand A, Katon WJ, et al. Adult health status of women with histories of childhood abuse and neglect. Am J Med. 1999;107(4):332-339. doi:10.1016/S02-9343(9)0235-1 PubMed (Pubitemid 29465810)
12. Newcomer JW, Haupt DW. The metabolic effects of antipsychotic medications. Can J Psychiatry. 2006;51(8):480-491. PubMed (Pubitemid 44166336)
13. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/ PSY SCREEN). New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
14. Goldstein BI, Levitt AJ. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder. Bipolar Disord. 2008;10(1):67-78. doi:10.1/j.139-5618.208.0461.x PubMed
15. Seretis D, Nika S, Nikolaidou P, et al. P03-540: Medical comorbidity in inpatients with schizophrenia and bipolar disorder: prevalence and length of stay. Eur Psychiatry. 2011;26(suppl 1):1710. doi:10.1016/S0924-938(1)73414-9
16. Zimmerman M, Chelminski I, Posternak MA. Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included. J Nerv Ment Dis. 2004;192(2):87-94. doi:10.1097/01.nmd.010279.23893.82 PubMed (Pubitemid 38248899)
17. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11(3):225-255. doi:10.1/j.139-5618.209.0672.x PubMed
18. Management of Bipolar Disorder in Adults (BD). Department of Veterans Affairs/Department of Defense Web site. http://www.healthquality.va.gov/ Management-of-Bi.asp. Updated 2010. Accessed August 3, 2011.